Pacira BioSciences reports sales of $54.9M for October

Nov. 14, 2022 8:33 AM ETPacira BioSciences, Inc. (PCRX)By: Preeti Singh, SA News Editor
  • Pacira BioSciences (NASDAQ:PCRX) has reported prelim net product sales of $54.9M for October 2022.
  • EXPAREL net product sales were $45M, compared with $42.5M for October 2021, with average daily sales up 106% Y/Y.
  • ZILRETTA net product sales were $8.6M, while iovera net product sales were $1.3M vs. $1.2M last year.
  • The company is not providing 2022 revenue or gross margin guidance at this time given the continued uncertainty around labor shortages, COVID-19, and the pace of recovery for the elective surgery market.
  • Take a look at PCRX's recent quarterly performance

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.